| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |